Catalyst Wire Dossier Catalyst Wire Dossier

VV913

· Vigonvita Life Sciences
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for VV913, covering 2026-01-28 to 2026-01-28. Get the full timeline:

Most recent: Clinical Trial Update: Study of the Safety, Tolerability, Pharmacokinetics of VV913 Capsules in Chinese Healthy Participants [Phase 1]

See pricing